CTKB EBITDA Growth
Cytek Biosciences Inc · EBITDA Growth
CTKB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-150.67%period ending
CTKB TTM EBITDA YoY % (-41.94% → -150.67%)
Year-over-year change
High-resolution chart · PNG
CTKB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -150.6739% | |
| -84.0994% | |
| -58.9115% | |
| -2,693.8367% | |
| -127.3242% | |
| -205.821% | |
| -127.5862% | |
| 86.1117% | |
| -1,180.914% | |
| -213.0135% | |
| -150.0682% | |
| -224.2819% | |
| -111.6432% | |
| -50.1575% | |
| -1.3115% | |
| -76.1875% | |
| -84.1541% | |
| -57.9682% | |
| -41.9433% |